Some health experts view GLP-1s as a promising option for PCOS, which lacks a standard treatment and affects millions of ...

Experts worry the warning on vaginal estrogen menopause treatments is doing more harm than good and is not supported by science.

A panel selected by FDA Commissioner Marty Makary, MD, MPH, unanimously urged the agency to remove the boxed warning on ...

JUUL GETS ITS CROWN — The FDA authorized Juul’s applications on Thursday to sell e-cigarettes in the U.S., determining ...

Due to biological differences in metabolism, body composition, and hormones, men generally burn more calories than women.

An article in The Journal For Nurse Practitioners found that Depo-Testosterone was the most cost-efficient TRT option, and ...

The FDA is reevaluating longtime warnings on hormone replacement therapy products for menopausal women. Some advocates for ...

Members of an FDA expert panel discussed reassessing boxed warnings for menopausal HT and how to better educate patients and ...

The FDA is reconsidering the black box warning on estrogen. Experts say it’s time for a change—find out what this means for ...

A panel of 12 experts in the menopause field reexamined the findings of the 2002 Women’s Health Initiative study that said ...

A decades-old label has scared women (and their doctors) away from safe and effective menopause treatment. That could finally change today.

US health authorities on Thursday began a reassessment of the risks surrounding Hormone Replacement Therapy (HRT), a ...